Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
Background: Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 0•85 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however...
Main Authors: | Hsiang-Ling Ho, Fang-Yu Wang, Hao-Ru Lee, Ya-Lan Huang, Chien-Liang Lai, Wen-Chin Jen, Shie-Liang Hsieh, Teh-Ying Chou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | The Lancet Regional Health. Western Pacific |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606520300419 |
Similar Items
-
Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats
by: Daniel J. Nesbitt, et al.
Published: (2021-08-01) -
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2
by: Pellegrino Cerino, et al.
Published: (2021-04-01) -
Seroprevalence of Influenza A(H1N1)pdm09 Virus Antibody, England, 2010 and 2011
by: Katja Hoschler, et al.
Published: (2012-11-01) -
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
by: Ritu Gupta, et al.
Published: (2021-01-01) -
Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia
by: Ayman Banjar, et al.
Published: (2021-03-01)